Garcia Schüler, Helena Isabel http://orcid.org/0000-0003-0874-9262
Pavic, Matea
Mayinger, Michael
Weitkamp, Nienke
Chamberlain, Madalyne
Reiner, Cäcilia
Linsenmeier, Claudia
Balermpas, Panagiotis
Krayenbühl, Jerome
Guckenberger, Matthias
Baumgartl, Michael
Wilke, Lotte
Tanadini-Lang, Stephanie
Andratschke, Nicolaus
Funding for this research was provided by:
schweizerischer nationalfonds zur förderung der wissenschaftlichen forschung (177080)
Article History
Received: 23 June 2021
Accepted: 3 November 2021
First Online: 14 November 2021
Declarations
:
: All patients but five treated at the MR-LINAC provided written general consent for further use of their data. These five patients were excluded from further clinical analysis. The analysis was approved by the cantonal ethics committee Zurich (BASEC-Nr. 2018-01794).
: Not applicable.
: HGS, NW, MC, CR, CL, PB, JK, MG, MB, LW have no conflicts of interest to disclose. MP reports receipt of Grant by ViewRay Inc, not yet activated, outside the submitted work. MM reports receipt of Grants of the Swiss Academy of Medical Sciences and Bangerter-Rhyner Foundation, outside the submitted work. STL reports others from Varian Medical Systems, outside the submitted work. NA reports receipt of equipment materials by ViewRay Inc, Grants from Brainlab AG and ViewRay Inc, consulting fees from AstraZeneca and Debiopharm, Honoraria from Brainlab AG and Viewray inc, Fiducial role as Chair of EORTC RTQA, and Editorial Board of Radiation Oncology, BMC Cancer and tipsRO, all outside the submitted work.